Income Statement Shenzhen RongDa Photosensitive Science & Technology Co., Ltd.
Stocks
300576
CNE100002DX7
Specialty Chemicals
|
End-of-day quote
Shenzhen S.E.
25/08/2026
|
5-day change | 1st Jan Change | ||
| 29.62 CNY | -0.90% |
|
-12.37% | -15.48% |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 784M | 734M | 798M | 948M | 1.07B | |||||
Other Revenues, Total | 1.5M | 1.37M | 1.29M | 1.3M | 1.21M | |||||
Total Revenues | 786M | 735M | 799M | 949M | 1.07B | |||||
Cost of Goods Sold, Total | 568M | 527M | 510M | 599M | 676M | |||||
Gross Profit | 218M | 208M | 289M | 351M | 393M | |||||
Selling General & Admin Expenses, Total | 126M | 116M | 120M | 145M | 173M | |||||
Provision for Bad Debts | 2.38M | 1.44M | 4.94M | 9.19M | 6.89M | |||||
R&D Expenses | 41.06M | 36.9M | 43.03M | 50.55M | 60.87M | |||||
Other Operating Expenses | 4.61M | 4.93M | 5.92M | 6.64M | 9.22M | |||||
Other Operating Expenses, Total | 174M | 159M | 174M | 212M | 250M | |||||
Operating Income | 44.27M | 49.27M | 115M | 139M | 143M | |||||
Interest Expense, Total | -5.21M | -801K | -508K | -558K | -398K | |||||
Interest And Investment Income | 1.76M | 1.2M | 2.96M | 3.6M | 4.11M | |||||
Net Interest Expenses | -3.45M | 401K | 2.45M | 3.04M | 3.71M | |||||
Currency Exchange Gains (Loss) | -1.75K | -21.44K | 189K | -2.1M | -997K | |||||
Other Non Operating Income (Expenses) | -234K | -285K | -260K | -318K | -389K | |||||
EBT, Excl. Unusual Items | 40.58M | 49.36M | 118M | 140M | 146M | |||||
Impairment of Goodwill | - | - | -4.24M | - | - | |||||
Gain (Loss) On Sale Of Investments | - | -2.96M | -21.17M | -4.24M | -1.31M | |||||
Gain (Loss) On Sale Of Assets | - | -54.54K | -197K | 154K | 687K | |||||
Asset Writedown | -110K | -390K | -584K | -344K | -786K | |||||
Other Unusual Items | 5.21M | 11.26M | 5.67M | 6.31M | -1.2M | |||||
EBT, Incl. Unusual Items | 45.68M | 57.22M | 97.17M | 142M | 143M | |||||
Income Tax Expense | 5.65M | 5.88M | 12.73M | 18.9M | 24.87M | |||||
Earnings From Continuing Operations | 40.03M | 51.34M | 84.43M | 123M | 118M | |||||
Net Income to Company | 40.03M | 51.34M | 84.43M | 123M | 118M | |||||
Minority Interest | -25.48K | 1.34M | 1.05M | -446K | 101K | |||||
Net Income - (IS) | 40M | 52.67M | 85.49M | 122M | 118M | |||||
Net Income to Common Incl Extra Items | 40M | 52.67M | 85.49M | 122M | 118M | |||||
Net Income to Common Excl. Extra Items | 40M | 52.67M | 85.49M | 122M | 118M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.11 | 0.14 | 0.23 | 0.31 | 0.29 | |||||
Basic EPS - Continuing Operations | 0.11 | 0.14 | 0.23 | 0.31 | 0.29 | |||||
Basic Weighted Average Shares Outstanding | 365M | 367M | 376M | 390M | 406M | |||||
Net EPS - Diluted | 0.11 | 0.14 | 0.22 | 0.31 | 0.29 | |||||
Diluted EPS - Continuing Operations | 0.11 | 0.14 | 0.22 | 0.31 | 0.29 | |||||
Diluted Weighted Average Shares Outstanding | 365M | 367M | 387M | 391M | 406M | |||||
Normalized Basic EPS | 0.07 | 0.09 | 0.2 | 0.22 | 0.22 | |||||
Normalized Diluted EPS | 0.07 | 0.09 | 0.19 | 0.22 | 0.22 | |||||
Dividend Per Share | 0.02 | 0.03 | 0.05 | 0.07 | 0.06 | |||||
Payout Ratio | 31.35 | 17.78 | 12.52 | 15.11 | 23.22 | |||||
Supplemental Items | ||||||||||
EBITDA | 60.29M | 66.88M | 133M | 158M | 176M | |||||
EBITA | 45.61M | 50.98M | 117M | 141M | 145M | |||||
EBIT | 44.27M | 49.27M | 115M | 139M | 143M | |||||
EBITDAR | 61.13M | 68.16M | 141M | 160M | 178M | |||||
Total Revenues (As Reported) | 786M | 735M | 799M | 949M | 1.07B | |||||
Effective Tax Rate - (Ratio) | 12.37 | 10.28 | 13.11 | 13.34 | 17.4 | |||||
Current Domestic Taxes | 7.95M | 8.6M | 11.17M | - | 25.67M | |||||
Total Current Taxes | 7.95M | 8.6M | 11.17M | 19.36M | 25.67M | |||||
Deferred Domestic Taxes | -2.3M | -2.72M | 1.57M | - | -800K | |||||
Total Deferred Taxes | -2.3M | -2.72M | 1.57M | -464K | -800K | |||||
Normalized Net Income | 25.34M | 32.19M | 74.61M | 86.94M | 91.04M | |||||
Interest Capitalized | - | - | - | - | - | |||||
Interest on Long-Term Debt | 5.05M | 537K | 508K | 558K | 397K | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 708K | 240K | 659K | 894K | 140K | |||||
Marketing Expenses | 84.89K | 65.34K | 39.59K | 72.95K | 20.59K | |||||
Selling and Marketing Expenses | 62.17M | 55.97M | 68.14M | 85.16M | 99.64M | |||||
General and Administrative Expenses | 63.32M | 59.31M | 50.05M | 58.33M | 71.99M | |||||
Research And Development Expense From Footnotes | 41.17M | 37.01M | 44.14M | 51.8M | 62.25M | |||||
Net Rental Expense, Total | 844K | 1.28M | 7.39M | 2.6M | 2.41M | |||||
Imputed Operating Lease Interest Expense | - | 121K | 2.98M | 949K | 865K | |||||
Imputed Operating Lease Depreciation | - | 1.16M | 4.41M | 1.65M | 1.54M | |||||
Stock-Based Comp., R&D Exp. (Total) | 5.83M | 227K | - | 940K | 7.85M | |||||
Stock-Based Comp., S&M Exp. (Total) | - | - | - | 5.16M | 2.88M | |||||
Stock-Based Comp., G&A Exp. (Total) | 14.19M | 492K | - | 6.69M | 816K | |||||
Total Stock-Based Compensation | 20.02M | 719K | - | 12.79M | 11.55M |
Select your edition
All financial news and data tailored to specific country editions
















